Evaluation of GLR2007 for Advanced Solid Tumors

Clinical trial NCT04444427 · COMPLETED

Trial details

NCT number: NCT04444427
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Glioblastoma Multiforme

Start date: 2020-07-15
Primary completion: 2022-07-29
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.